Patents by Inventor Jeffrey I. ZWICKER

Jeffrey I. ZWICKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT
    Publication number: 20240133897
    Abstract: The present invention relates to compositions and methods for identifying at-risk patients and modulating thrombotic conditions in a cancer patient. Embodiments provided herein include a method of determining risk for a thrombotic event in a cancer patient comprising: detecting in a sample of a patient with cancer elevated levels of PPIA, PDIA3 and at least one of EIF5A, EIF4H, EIF4a3, UBE2N, UBE2L3, UBE2I, and HSP70.
    Type: Application
    Filed: December 9, 2020
    Publication date: April 25, 2024
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Jeffrey I. Zwicker, Robert Flaumenhaft
  • Compositions and methods for reducing major thrombotic events in cancer patients
    Patent number: 11872241
    Abstract: The present invention relates to methods for reducing soluble P-selectin and major thrombotic events in cancer patients.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: January 16, 2024
    Assignee: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
    Inventors: Jeffrey I. Zwicker, Bruce Furie, Jack Davis Stopa, Robert Flaumenhaft
  • METHOD FOR TREATING SICKLE CELL DISEASE USING QUERCETIN-CONTAINING COMPOSITIONS
    Publication number: 20230029216
    Abstract: Disclosed are compositions and methods for treating sickle cell disease. Also disclosed are methods of treating sickle cell disease comprising administering to a subject in need thereof an effective amount of isoquercetin, vitamin B3, vitamin C, and optionally folic acid and wherein the effective amount is sufficient to halt progression of one or more of the symptoms of sickle cell disease.
    Type: Application
    Filed: July 15, 2022
    Publication date: January 26, 2023
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Jeffrey I. ZWICKER, Bruce FURIE, Robert FLAUMENHAFT
  • COMPOSITIONS AND METHODS FOR REDUCING MAJOR THROMBOTIC EVENTS IN CANCER PATIENTS
    Publication number: 20200171064
    Abstract: The present invention relates to methods for reducing soluble P-selectin and major thrombotic events in cancer patients.
    Type: Application
    Filed: November 26, 2019
    Publication date: June 4, 2020
    Inventors: Jeffrey I. ZWICKER, Bruce FURIE, Jack Davis STOPA, Robert FLAUMENHAFT